Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. NVDA
2. RKLB
3. SPY
4. SION
5. B
6. MNDY
7. CSQR
8. ACH
9. ACVA
10. INTC

Go back to Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
(NASDAQ: VERU) Delayed: 2.77 --0 (-0%)
Previous Close $2.77    52 Week High $ 
Open $2.77    52 Week Low $ 
Day High $2.77    P/E N/A 
Day Low $2.77    EPS $ 
Volume 915